GHCM
KURA icon

Glen Harbor Capital Management’s Kura Oncology KURA Stock Holding History

Glen Harbor Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$30K Hold
2,006
– – ﹤0.01% 1272
2019
Q2 		$40K Sell
2,006
-1,836
-48% -$30.5K ﹤0.01% 1264
2019
Q1 		$64K Hold
3,842
– – ﹤0.01% 1207
2018
Q4 		$54K Sell
3,842
-33,558
-90% -$445K ﹤0.01% 1184
2018
Q3 		$655K Buy
37,400
+1,666
+5% +$31.9K 0.01% 606
2018
Q2 		$650K Sell
35,734
-3,196
-8% -$54.1K 0.01% 560
2018
Q1 		$730K Buy
+38,930
New +$758K 0.02% 502

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Glen Harbor Capital Management's KURA Position: Q3 2019 in Review

Glen Harbor Capital Management held its Kura Oncology (KURA) position steady in Q3 2019 at 2,006 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #1272.

Glen Harbor Capital Management first reported a position in KURA in Q1 2018 and has held it in 7 quarters since. The position peaked at $730K in Q1 2018. 116 funds tracked by Wall St. Rank hold KURA as of Q3 2019.

  • Glen Harbor Capital Management held 2,006 shares of Kura Oncology worth $30K as of Q3 2019.
  • Glen Harbor Capital Management left its Kura Oncology share count unchanged in Q3 2019.
  • Kura Oncology made up ﹤0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #1272 holding.
  • Glen Harbor Capital Management first reported a position in Kura Oncology in Q1 2018 and has held it in 7 quarters since.
  • Glen Harbor Capital Management's Kura Oncology position peaked at $730K in Q1 2018.
  • 116 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.